Loading data for XBIT — first visit, this takes a few seconds.

Alerta

XBiotech Inc. (XBIT)

NasdaqGS: XBIT · Precio en tiempo real · USD

2.28

-0.03 (-1.30%)

Al cierre: Aug 27, 2026, 7:22 PM

El precio, las cifras principales y las últimas noticias, en un solo sitio.

-1.30% (1D)

No hay datos disponibles

Precio de compra	1.66
Capitalización de mercado	70.12M
Ingresos (TTM)	n/a
Beneficio neto (TTM)	-45.13M
	0.85
	-1.48
	n/a
	17.69
P/B (TTM)	0.55
P/S (TTM)	n/a
Fecha de resultados	May 11, 2020

Precio de venta	2.96
Volumen	11,016
Volumen medio (20D)	33,772
Abierto	2.26
Anterior Cerrar	2.31
Rango del día	2.26 - 2.32
Rango de 52 semanas	2.09 - 3.61
analista	n/a
Precio objetivo	n/a
Dividendos	n/a
Fecha ex dividendo	15 jul 2021

Acerca de XBIT

XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malai...

[Leer más]

Industria Biotechnology

Sector Healthcare

IPO Fecha Apr 15, 2015

Empleados 87

Bolsa de Valores NasdaqGS

Símbolo bursátil XBIT

Sitio web https://www.xbiotech.com

Perfil completo de la empresa

Desempeño financiero

En 2025, los ingresos de XBiotech fueron 0, un aumento de undefined% en comparación con 0 del año anterior. Las ganancias fueron -45.54M, un aumento de 18.19%.

Estados financieros

Sorpresa de resultados

XBiotech ha publicado sus resultados trimestrales en Mar 16, 2020:

Ingresos de $0 falla las estimaciones por $0, con NaN% Crecimiento interanual.
EPS de -0.28 falla las estimaciones por -0.13, con 45.10% Crecimiento interanual.

Próxima publicación de resultados

Está previsto que XBiotech Inc. publique sus resultados el May 11, 2020, después del cierre del mercado.
Los analistas proyectan ingresos de ... Actualizar

Noticias

5 meses hace · Associated Press Finance

XBiotech: Q4 Earnings Snapshot

AUSTIN, Texas (AP) — XBiotech Inc. XBIT) on Friday reported a loss of $26.9 million in its fourth quarter. On a per-share basis, the Austin, Texas-based company said it had a loss of 88 cents.

8 meses hace · Simply Wall St.

3 Promising Penny Stocks With Market Caps Over $30M

Major stock indexes in the United States have recently experienced a surge, driven by gains in technology shares and positive economic indicators. While the term "penny stocks" might seem outdated, it...

9 meses hace · Simply Wall St.

November 2025's Promising Penny Stocks To Watch

As the Dow Jones Industrial Average reaches an all-time high amid optimism over the potential end of a prolonged U.S. government shutdown, investors are keenly observing market dynamics and seeking op...

9 meses hace · Associated Press Finance

XBiotech: Q3 Earnings Snapshot

AUSTIN, Texas (AP) — XBiotech Inc. XBIT) on Wednesday reported a loss of $6 million in its third quarter. The Austin, Texas-based company said it had a loss of 20 cents per share.

12 meses hace · Simply Wall St.

XBiotech Inc.'s (NASDAQ:XBIT) top owners are retail investors with 52% stake, while 36% is held by insiders

Key Insights Significant control over XBiotech by retail investors implies that the general public has more power to...

XBiotech Inc. (XBIT)